With comments as “the project is likely to have a significant impact”, and “this project will make a substantial contribution to the expected impact”, the reviewers of the European Union agency EDCTP approved for funding another new project: “LiberHetica: increasing the ethics capacity of oversight for clinical trials in Liberia by establishing European-African collaborations that facilitates implementation of efficient processes …”. A great team lead by Liberian institutional rapresentatives made this come true, therefore I would like to thank Dr. Bolay Fotorma, Jemee Tegli, Dr. Stephen B. Kennedy, Gloria Mason, and Cecilia Morris.

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

ImproViTB

With 1 million new cases and 200,000 children dead each year, Tuberculosis (TB) is now the leading cause of death from infectious diseases for children of all ages globally (UNICEF).

Ebola vaccines at a la glance

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including

Exemplary coordination of African researchers and scientists

Exemplary coordination of African researchers and scientists involved in the response to the pandemic to study treatments that prevent serious complications of COVID-19 https://bit.ly/37SvaCz